St. Louis Local News

iotaMotion Announces Formation Of Scientific Advisory Board For Robotic-Assisted Cochlear Technologies

14 12 2017

IOWA CITY, Iowa, Dec. 14, 2017 -- iotaMotion, Inc., a medical device company focused on developing advanced robotic systems for cochlear implant surgery, announced today the formation of its Scientific Advisory Board (SAB) with two key appointments: Craig A. Buchman, M.D., and J. Thomas Roland Jr., M.D. two world-renowned cochlear implant surgeons, who join Dr. Bruce Gantz (Chair and Head of the Department of Otolaryngology – Head and Neck Surgery at the University of Iowa) who serves as an esteemed advisor to the company. The SAB will work closely with the iotaMotion management team as it advances its product pipeline. The company is developing technology that will enable surgeons to achieve more precise, individualized solutions for patients experiencing various types of hearing loss. The company's first product, iotaSOFT™, is a robotic-assisted insertion device that allows surgeons to advance cochlear implant electrodes with the precision of robotics. Controlled insertion...

Johns Joins Cejka Executive Search As Executive Vice President, Managing Principal

14 12 2017

ST. LOUIS, Dec. 14, 2017 -- Cejka Executive Search, ranked on Forbes list of America's Best Executive Recruiting Firms, is pleased to announce that Alan D. Johns has joined the firm as Executive Vice President, Managing Principal to lead the firm's Academic Medicine and Health Sciences Practice. Johns brings three decades of experience in higher education/academic health sciences administration, finance, operations, strategic planning, research administration, risk assessment and accountability to Cejka Executive Search. Prior to joining executive search four years ago, Johns served in senior leadership positions at public and private, research-intensive universities, including Columbia University College of Physicians and Surgeons (Associate Vice Dean and CFO), Duke University School of Medicine (Associate Dean for Strategic Services and Chief Academic Administrative Officer for Duke Comprehensive Cancer Center), Virginia Commonwealth University (Assistant Vice President...

RGA Releases 2017 Global Life and Health Underwriting Survey

14 12 2017

ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life reinsurer, today released its 2017 Global Life and Health Underwriting Survey. The survey was conducted among 25 leading life and health insurers from large global, regional, and single-market companies. The findings demonstrate that the practice of underwriting is being challenged to play a leading role in the transformation of business processes and the deployment of business development strategies. Respondents indicated that enhanced customer experience, emerging consumer demand, the ability to use more data-driven approaches, and cost efficiency are driving the shift towards less reliance on traditional underwriting. As many insurers shift towards a consumer-centric approach, a globally emerging trend is for less reliance on “one-size-fits-all” products and a renewed focus on more segment-specific strategies. “Based on the 2017 survey results, it is apparent that transformations...

Convenient Nail-Polish Remover Developed by InventHelp Inventor (SLC-1124)

14 12 2017

PITTSBURGH December 14, 2017 "I want my nails to look perfect, but I do not want to spend precious time removing nail polish," said an inventor from Decatur, Ill. "For this reason, I came up with a much more convenient way to remove nail polish from my toes." She developed the NAILED IT to offer an efficient way to remove nail polish from toenails. The design eliminates the need to use cotton balls to wipe away nail polish. This saves time and effort. The unit makes for a more professional-looking pedicure. It reduces the need to visit the salon to have nails done. Furthermore, the invention ensures that nails look shiny and polished. The original design was submitted to the St. Louis office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 16-SLC-1124, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at...

Akcea Initiates Phase 2 Study of AKCEA-ANGPTL3-LRx in Patients with Hypertriglyceridemia, Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)

14 12 2017

CAMBRIDGE, Mass., Dec. 14, 2017 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders, today announced the initiation of a Phase 2 program of AKCEA-ANGPTL3-LRx in patients with hypertriglyceridemia, type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD). The primary goal of the study is to determine the dose level and frequency for use of AKCEA-ANGPTL3-LRx in future registration studies.AKCEA-ANGPTL3-LRx is designed to target and reduce the production of angiopoietin-like 3, or ANGPTL3, a protein produced and secreted by the liver. The congenital absence of ANGPTL3 is associated with lower lipid levels and reduced risk of insulin resistance, diabetes mellitus and cardiovascular disease relative to individuals with normal production of ANGPTL3 protein. “To date, we have seen that ANGPTL3 modulates multiple...

Rubius Therapeutics Strengthens Leadership Team with Appointment of Andrew Oh as Chief Financial Officer

14 12 2017

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rubius Therapeutics, a biotechnology company pioneering the creation of a new class of extraordinarily active, ready-to-use and life-changing cellular therapies, today announced the appointment of Andrew Oh as Chief Financial Officer. Mr. Oh brings to Rubius more than 20 years of experience in finance and the biopharmaceutical industry. Prior to joining Rubius, Mr. Oh served as Chief Investment Officer and Chief Operating Officer at Leerink Pharmaceutical Investments, a subsidiary of Leerink Capital Partners. Prior to Leerink, Mr. Oh was a senior analyst covering global pharmaceutical companies and was a portfolio manager at Fidelity Investments for seven years. Mr. Oh managed the Fidelity Select Pharmaceuticals Portfolio fund which was rated by Lipper as the number one global health/biotechnology fund based on three and five year performance. He received a B.A. in Biology from Washington University in St. Louis and holds a MBA from Northwestern’s...

BrainChip Announces Change in Board Membership

14 12 2017

SAN FRANCISCO, Dec. 14, 2017 -- BrainChip Holdings Ltd. (“BrainChip” or the “Company”) (ASX:BRN), a leading developer of software and hardware accelerated solutions for advanced artificial intelligence (AI) and machine learning applications, today announced that Peter van der Made, Chief Technology Officer (CTO) and Founder of BrainChip, will be resigning his position as Director on the BrainChip Board effective January 1, 2018. Mr. van der Made will focus exclusively on the development and introduction of Akida, BrainChip’s next generation Neuromorphic System-on-Chip (NSoC) processor unit.Mr. Mick Bolto, Chairman of BrainChip, commented, “Peter has been instrumental in the creation and guidance of BrainChip. Over the past eighteen months we have strengthened our Board with the addition of Mr. Louis DiNardo, Ms. Julie H. Stein, and most recently Mr. Emmanuel (Manny) Hernandez. We are now in a position to enable Peter to devote one hundred percent of his energy to the development...

Mesothelioma Victims Center Now Urges a Diagnosed Navy Veteran to Call for Direct Access to The Nation's Top Compensation Lawyers if their Asbestos Exposure Occurred at A Shipyard

14 12 2017

    NEW YORK, NY, December 14, 2017 -- The Mesothelioma Victims Center is passionate about being a top branded advocate for US Navy Veterans with mesothelioma. The group's number one priority is seeing to it that people like this receive the best possible financial compensation settlement. The group is especially focused on assisting US Navy Veterans who have mesothelioma if they were assigned to a ship at a shipyard where their exposure to asbestos would have probably been extreme.A US Navy Veteran who has recently received news of a mesothelioma diagnosis is urged to contact the Mesothelioma Victims Center anytime at 800-714-0303 for their unsurpassed free services. One of these services includes on-the-spot access to some of the nation's most experienced mesothelioma attorneys who work their tails off to make certain their client receives the very best possible financial compensation. At the same time, the group would like to steer a US Navy Veteran or their...

Akhouri Achyutanand Sinha, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

14 12 2017

    MINNEAPOLIS, MN, December 14, 2017 -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Akhouri Achyutanand Sinha, PhD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Sinha celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.Dr. Sinha is currently studying the characteristics of prostate cancer stem cells and aggressiveness of prostate cancer, in addition to proliferation and cell death. He is employed at the University of Minnesota's college of biological...

VantagePoint Software Now Forecasting Bitcoin and Other Cryptocurrencies Utilizing Patented A.I. Technology

14 12 2017

WESLEY CHAPEL, Fla., Dec. 13, 2017 -- VantagePoint Software, using patented Artificial Intelligence technology to predict stock market trends and trend changes made the official announcement today that traders can now use the software to forecast Cryptocurrencies.As a result of the recent growth in popularity of Cryptocurrencies and the outpouring of requests from current VantagePoint Software users, the VantagePoint R&D team began focusing on adapting the Artificial Intelligence forecasting technology for Cryptocurrencies.  Since 1991, VantagePoint has been able to consistently achieve over 80% accuracy in stocks and commodities due to the deep learning neural network technology that has been developed and refined over the past three decades (more information about the use of Artificial Intelligence can be found at www.VantagepointSoftware.com).After considerable time spent testing and adapting the artificial intelligence to Cryptocurrency data VantagePoint Software...

Live Traffic in St. Louis, MO